Explore our diverse design and manufacturing capabilities spanning precision-engineered toys, sensory education kits, and dynamic consumer solutions.
Unlocking industrial scale and efficacy parameters in global veterinary wellness markets.
The global demand for veterinary ectoparasiticides has undergone a monumental shift. No longer confined to reactive treatment paradigms, pet owners and veterinary practitioners demand highly preventative, targeted, and broad-spectrum solutions. The market is increasingly driven by advanced formulations that guarantee long-lasting protection against Siphonaptera (fleas) and Ixodida (ticks), which serve as key vectors for zoonotic threats such as Lyme disease, Rocky Mountain spotted fever, and anaplasmosis.
As contract manufacturing (OEM/ODM) becomes the linchpin for global pet wellness brands, factories must establish specialized production standards. Success in this vertical requires a sophisticated understanding of pesticide chemistry, transdermal carrier systems, and oral palatability enhancers. For brands seeking to command market share across North America, the European Union, and Asia-Pacific, selecting an OEM partner with comprehensive regulatory dossiers and validated chemical processes is critical.
Processing spot-on topicals, chewable tablets, and matrix-infused plastic collars using specialized extrusion and liquid-filling technology.
Precise handling of active pharmaceutical ingredients (APIs) such as Fipronil, (S)-Methoprene, Imidacloprid, Permethrin, and advanced Isoxazolines.
Engineered lipophilic carrier systems to optimize transdermal absorption and ensure rapid, systemic insecticidal action across the skin surface.
Inside the molecular science and manufacturing processes of premium canine antiparasitics.
Developing high-efficacy veterinary therapeutics demands a balance of pharmacology, material science, and canine behavior. As a leading OEM factory, our development pipeline is divided into three key delivery mechanisms:
Liquid treatments applied directly to the dog's skin, relying on transdermal migration through the lipid layer of the epidermis.
Systemic oral treatments requiring highly controlled dosing and high palatability profiles to ensure voluntary acceptance.
Extended-release options that deliver active ingredients steadily over a period of 6 to 8 months.
Adapting parasiticide profiles to environmental climates and regional ectoparasite pressures.
Challenge: High ambient temperatures and humidity accelerate flea breeding cycles and tick activity year-round, requiring formulations that withstand heavy precipitation and sweat.
Solution: High-lipophilic topicals containing Permethrin and Dinotefuran, or oral Isoxazoline therapies that remain unaffected by frequent bathing, grooming, or swimming.
Challenge: Prevalence of hard-bodied ticks (such as Ixodes scapularis and Amblyomma americanum) capable of transmitting Lyme disease and Ehrlichiosis.
Solution: Formulations emphasizing rapid tick detachment and mortality, leveraging Permethrin for its contact-repellent effect, combined with Fipronil or Fluralaner to disrupt neuro-transmissions before pathogen transmission occurs.
Challenge: Hypersensitive domestic dogs where a single bite can trigger severe dermatological distress and secondary pyoderma.
Solution: Fast-acting oral adulticides like Nitenpyram combined with long-term preventative APIs. Rapid onset of action (within 30 minutes) eliminates the feeding flea population before they can trigger allergic reactions.
Challenge: Hunting, rescue, and active working breeds exposed to thick brush, stagnant water, and severe insect vector pressures.
Solution: Broad-spectrum combination treatments (flea, tick, heartworm, and intestinal parasite control) delivering systemic defense under heavy physical stress and variable environmental exposures.
How our integrated operations ensure material availability, production speed, and quality control.
In the veterinary pharmaceutical domain, supply chain disruption can compromise product launches and shelf presence. By leveraging China’s highly integrated chemical manufacturing clusters, our factory guarantees uninterrupted access to key precursors and active pharmaceutical ingredients (APIs). Our strategic location allows us to maintain close relationships with upstream chemical synthesizers, optimizing procurement costs and minimizing lead times for key ingredients like Fipronil and Imidacloprid.
Beyond material sourcing, our facilities utilize advanced automation across blending, dosing, packaging, and cartooning phases. With high-speed automated packaging lines, we minimize human contamination risks and optimize packaging integrity. This level of production efficiency translates to a highly competitive cost-per-unit, allowing global brands to achieve strong gross margins while maintaining strict compliance with global quality and regulatory standards.
Direct sourcing channels for high-grade active ingredients, reducing dependency on volatile intermediary brokers and stabilizing raw material costs.
In-line weight checks, vision inspection systems, and automated leak detection to ensure every blister pack and tube meets rigorous seal-integrity standards.
Coordinated transit protocols with leading sea, air, and rail carriers, ensuring fast distribution to North American, European, and Asian hub ports.
Navigating complex international product registrations and quality dossiers.
Bringing new ectoparasiticide formulations to market requires strict adherence to regional regulatory frameworks. Since these products often fall under both veterinary medicine and pesticide classifications, compliance pathways can vary significantly by jurisdiction:
Topical and collar products are regulated by the Environmental Protection Agency (EPA) under FIFRA, requiring extensive toxicology, environmental fate, and product performance studies. Oral chewables fall under the Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM), necessitating strict Target Animal Safety (TAS) trials and NADA/ANADA approvals.
Regulated by the European Medicines Agency (EMA) under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6). All products must go through centralized or decentralized authorization pathways, requiring complete chemistry, manufacturing, and controls (CMC) documentation along with environmental risk assessments.
Regulated by agencies like the Australian Pesticides and Veterinary Medicines Authority (APVMA) and domestic ministries of agriculture. Registration requires local efficacy data proving performance against native pest strains under regional climatic conditions.
We started as a small toy export company with just two person, operating from an office of less than 20 square meters and struggling with limited cash flow. Yet, through keen market insights, distinctive business strategies, and patient communication with our clients, we gradually earned recognition and trust. We understood early on that clients are not only looking for products, but also for partners who can truly solve problems and create value. With every collaboration, we strived to provide practical solutions and dedicated service, winning customer appreciation while accumulating valuable experience and building stronger relationships.
Over time, as our reputation grew and our expertise deepened, Ducky evolved from a small trading company into a full-category procurement service provider for global B2B clients. Today, we possess extensive industry experience and a wide supply chain network, enabling us to offer comprehensive procurement services covering toys, household goods, and a wide range of other products. We remain committed to our founding principle: to listen attentively to client needs and deliver efficient, professional, and flexible procurement solutions. In today’s increasingly competitive global market, we are more than just a supplier—we are a trusted long-term partner to our clients.
We are committed to offering our clients the highest-quality products and services at competitive prices. We strive to become a leader in the industry, delivering excellence to our customers.
We have an office in Chenghai, Shantou—a dynamic hub of the toy and gift industry. Chenghai produces approximately 80% of the world’s toys. We collaborate closely with local manufacturers to create toys that meet international safety standards, ensuring every product is both safe and creative.
Throughout production, we pay attention to every detail, maintaining strict quality control so that each toy provides satisfaction and value to our customers.
We also have a professional logistics team to ensure that every product is delivered safely and efficiently. From procurement to transportation, we oversee every step of the process, working with reliable logistics companies to guarantee on-time delivery and uncompromised quality.
Answers to key chemical, regulatory, and logistics queries for international buyers.
Discover additional items from our diversified procurement portfolio designed for global distributors.
Ducky Sourcing